Skip to content

Study on Metastasis Mechanism of Oral Cancer Based on Multi-omics Sequencing

Study on Metastasis Mechanism of Oral Cancer Based on Multi-omics Sequencing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025758
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-09-06
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral cancer

Interventions

Case series:none

Sponsors

Department of Beijing Stomatological Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Understands the protocol and is able to give informed consent. 2) Male and female aged 18 to 75 years; 3) Oral squamous cell carcinoma confirmed by pathology in the first patient; 4) Location: tongue, buccal mucosa, maxillary gingiva, mandibular gingiva, floor of mouth, hard palate will be included; 5) Clinical stage(TNM) T1-4aN0-3M0; 6) Karnofsky score >60; 7) Surgery is the preferred treatment and the primary tumor can be excised with clear margins 8) Patients can be followed up regularly after operation according to follow up plan.

Exclusion criteria

Exclusion criteria: 1. Prior radiotherapy ,chemotherapy surgery for malignancy in the head and neck region or recurrent patient. 2. Significant clinical cardiovascular and cerebrovascular diseases, such as heart failure (NYHA III-IV), uncontrolled coronary heart disease, cardiomyopathy, uncontrolled arrhythmia, uncontrolled hypertension or previous half-year history of myocardial infarction or cerebral infarction; 3. History of malignant tumors outside the head and neck region of the body; 4. Known or self-reported HIV infection or active hepatitis B or C; 5. Patients have poor compliance and can not follow up on time; 6. Positive pregnancy test in female patients; 7. Other systemic diseases that do not conform to surgical indications; 8. Patients who refuse surgical treatment; 9. With prior malignancy outside the head and neck region in the preceding 5 years 10. Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
disease specific survival;

Secondary

MeasureTime frame
disease-free survival;Local recurrence free survival;neck recurrence free suvival;distant recurrence free survival;

Countries

China

Contacts

Public ContactZheng-Xue Han

Department of Beijing Stomatological Hospital, Capital Medical University

mmh_hover@163.com+86 010-57099150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026